[1] | Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics . GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2020; 71(3), 209–249. https://doi.org/10.3322/caac.21660. |
[2] | International, T., Epidemiology, C., Cheng, M. L., Zhang, L., Borok, M., Chokunonga, E., Dzamamala, C., Korir, A., Wabinga, H. R., Hiatt, R. A., Parkin, D. M., & Loon, K. Van. The incidence of oesophageal cancer in Eastern Africa: Identification of a new geographic hot spot? §. 2015; 39, 7821. |
[3] | Mathew, C. G., Middleton, D., Murphy, G., & Dawsey, S. M. (2022). The African Esophageal Cancer Consortium: A Call to Action. https://doi.org/10.1200/JGO.17.00163. |
[4] | Globocan. (2020). Kenya Source. 799, 2020–2021; https://gco.iarc.fr/today/data/factsheets/populations/404-kenya-fact-sheets.pdf. |
[5] | Car, L. T., Urch, C., Majeed, A., Khatib, M. El, Aylin, P., Atun, R., Car, J., Vincent, C., & Car, L. T. Correspondence to: Preventing delayed diagnosis of cancer: clinicians ’ views on main problems and solutions. 2016; 6(2). https://doi.org/10.7189/jogh.06.020901. |
[6] | Akuoko, C. P., Armah, E., Sarpong, T., Quansah, D. Y., Amankwaa, I., & Boateng, D. (2017a). Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa. 1–18. https://doi.org/10.1371/journal.pone.0171024. |
[7] | Espina, C., & Mckenzie, F. Annals of Epidemiology Delayed presentation and diagnosis of breast cancer in African women: a systematic review. Annals of Epidemiology. 2017; 27(10), 659-671. e7. https://doi.org/10.1016/j.annepidem.2017.09.007. |
[8] | Njuguna, F., Martijn, H., Langat, S., Musimbi, J., & Muliro, H. FACTORS INFLUENCING TIME TO DIAGNOSIS AND TREATMENT AMONG PEDIATRIC ONCOLOGY PATIENTS IN KENYA. n.d; .33(2016), 186–199. |
[9] | Patel, K., Wakhisi, J., Mining, S., Mwangi, A., & Patel, R. Esophageal Cancer , the Topmost Cancer at MTRH in the Rift Valley , Kenya , and Its Potential Risk Factors. 2013. |
[10] | Majur, M., & Mabior, C. Time To Presentation And Diagnosis In Patients With Esophageal Cancer At Kenyatta National Hospital. 2018. |
[11] | Wakhisi, J., Patel, K., Buziba, N., & Rotich, J. Esophageal cancer in north rift valley of western Kenya. 2005; 157–163. |
[12] | Wakhisi, J., Patel, K., Buziba, N., & Rotich, J. (2005). Esophageal cancer in north rift valley of western Kenya. African Health Sciences, 5(2), 157–163. |
[13] | Middleton, D. R. S., Bouaoun, L., Hanisch, R., Bray, F., Dzamalala, C., Chasimpha, S., Menya, D., Mbalawa, C. G., N’Da, G., Woldegeorgis, M. A., Njie, R., Koulibaly, M., Buziba, N., Ferro, J., Nouhou, H., Ogunbiyi, F., Wabinga, H. R., Chokunonga, E., Borok, M. Z., … McCormack, V. A. Esophageal cancer male to female incidence ratios in Africa: A systematic review and meta-analysis of geographic, time and age trends. Cancer Epidemiology. 2018; 119–128. https://doi.org/10.1016/j.canep.2018.01.020. |
[14] | Barasa, E., Rogo, K., Mwaura, N., & Chuma, J. Kenya national hospital insurance fund reforms: Implications and lessons for universal health coverage. Health Systems and Reform. 2018; 4(4), 346–361. https://doi.org/10.1080/23288604.2018.1513267. |
[15] | Greene, S. B., Othieno-abinya, N. A., & Bennett, A. V. Improving Access to Cancer Testing and Treatment in Kenya. 2018; 7. https://doi.org/10.1200/JGO.2017.010124. |
[16] | Wheeler, S., Bennett, A. V., Makau-Barasa, L. K., Othieno-Abinya, N. A., Greene, S. B., & Skinner, A. Improving Access to Cancer Testing and Treatment in Kenya. Journal of Global Oncology. 2017; 7(4), 1–8. https://doi.org/10.1200/jgo.2017.010124. |
[17] | Wambalaba, F. W., Son, B., Wambalaba, A. E., Nyong, D., & Nyong, A. (2019). Prevalence and Capacity of Cancer Diagnostics and Treatment: A Demand and Supply Survey of Health-Care Facilities in Kenya. 26, 1–12. https://doi.org/10.1177/1073274819886930. |
[18] | Chen, H., Chen, I., Chen, Y., Chen, C., & Chuang, C. (2022). The Influence of Socioeconomic Status on Esophageal Cancer in Taiwan: A Population-Based Study. |
[19] | Kou, K., Baade, P. D., Guo, X., Gatton, M., Cramb, S., Lu, Z., Fu, Z., Chu, J., Xu, A., & Sun, J. (2019). Area socioeconomic status is independently associated with esophageal cancer mortality in. Scientific Reports, November 2018, 1–8. https://doi.org/10.1038/s41598-019-42774-x. |
[20] | Wang, N., Cao, F., Liu, F., Jia, Y., Wang, J., Bao, C., Wang, X., Song, Q., Tan, B., & Cheng, Y. The effect of socioeconomic status on health care delay and treatment of esophageal cancer. Journal of Translational Medicine. 2015; 1–5. https://doi.org/10.1186/s12967-015-0579-9. |
[21] | Islami, F., Kamangar, F., Nasrollahzadeh, D., Aghcheli, K., Sotoudeh, M., Abedi-Ardekani, B., Merat, S., Nasseri-Moghaddam, S., Semnani, S., Sepehr, A., Wakefield, J., Møller, H., Abnet, C. C., Dawsey, S. M., Boffetta, P., & Malekzadeh, R. Socio-economic status and oesophageal cancer: Results from a population-based case-control study in a high-risk area. International Journal of Epidemiology. 2009; 38(4), 978–988. https://doi.org/10.1093/ije/dyp195. |
[22] | Jansson, C., Johansson, A. L. V, & Nyre, O. Socioeconomic Factors and Risk of Esophageal Adenocarcinoma: A Nationwide Swedish Case-Control Study. 2005 July 14; 1754–1762. |
[23] | Subramanian, S., Gakunga, R., Kibachio, J., Gathecha, G., Edwards, P., Ogola, E., Yonga, G., Busakhala, N., Munyoro, E., Chakaya, J., Ngugi, N., Mwangi, N., Rege, D. Von, Wangari, L. M., Wata, D., Makori, R., Mwangi, J., & Mwanda, W. Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors. 2018; PLoS ONE, 13(1), 1–16. https://doi.org/10.1371/journal.pone.0190113. |
[24] | Grotenhuis, B. A., van Hagen, P., Wijnhoven, B. P. L., Spaander, M. C. W., Tilanus, H. W., & van Lanschot, J. J. B. Delay in diagnostic workup and treatment of esophageal cancer. Journal of Gastrointestinal Surgery. 2010; 14(3), 476–483. https://doi.org/10.1007/s11605-009-1109-y. |
[25] | van Erp, N. F., Helsper, C. W., Slottje, P., Brandenbarg, D., Büchner, F. L., van Asselt, K. M., Muris, J. W. M., Kortekaas, M. F., Peeters, P. H. M., & de Wit, N. J. Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement? United European Gastroenterology Journal. 2020; 8(5), 607–620. https://doi.org/10.1177/2050640620917804. |
[26] | Gyenwali, D., Pariyar, J., & Onta, S. R. (2013). Factors Associated with Late Diagnosis of Cervical Cancer in Nepal. 14, 4373–4377. |
[27] | Makau-Barasa, L. K., Greene, S., Othieno-Abinya, N. A., Wheeler, S. B., Skinner, A., & Bennett, A. V. A review of Kenya’s cancer policies to improve access to cancer testing and treatment in the country. Health Research Policy and Systems. 2020; 18(1), 1–10. https://doi.org/10.1186/s12961-019-0506-2. |
[28] | Atieno, O. M., Opanga, S., Martin, A., Kurdi, A., Michelle, O., Opanga, S., Martin, A., & Kurdi, A. (2018). Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future. Journal of Medical Economics, 21(9), 878–887. https://doi.org/10.1080/13696998.2018.1484372. |